YU81303A - Inhibicija aromatazom u cilju poboljšanja asistirane reprodukcije - Google Patents
Inhibicija aromatazom u cilju poboljšanja asistirane reprodukcijeInfo
- Publication number
- YU81303A YU81303A YU81303A YUP81303A YU81303A YU 81303 A YU81303 A YU 81303A YU 81303 A YU81303 A YU 81303A YU P81303 A YUP81303 A YU P81303A YU 81303 A YU81303 A YU 81303A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- assisted reproduction
- enhance
- aromatase inhibition
- aromatase inhibitor
- cycles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Korišćenje najmanje jednog inhibitora aromataze za produkciju medikamenta za poboljšanje stope implantacije i trudnoće kod žena koje se podvrgavaju terapiji asistiranom reprodukcijom, gde ta terapija obuhvata najmanje jednu ili više dnevnih doza inhibitora aromataze (AI) za davanje tokom ciklusa asistirane reprodukcije ili ciklusa stimulacije ovarijuma, i gde se doze AI odabiraju iz količina koje su delotvorne za smanjivanje nivoa estradiola u serumu. Otkrivaju se i srodni farmaceutski preparati i pakovanja.[The use of at least one aromatase inhibitor in the production of a medicament for improving the implantation and pregnancy rates for a female undergoing assisted reproduction treatment, which comprises one or more daily doses of an aromatase inhibitor (AI) for administration during assisted reproduction cycles or ovarian stimulation cycles, wherein the doses of AI are selected from amounts effective to reduce serum estradiol levels. Also disclosed are related pharmaceutical preparations and packages.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28417801P | 2001-04-17 | 2001-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU81303A true YU81303A (sh) | 2006-05-25 |
Family
ID=23089175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU81303A YU81303A (sh) | 2001-04-17 | 2002-04-17 | Inhibicija aromatazom u cilju poboljšanja asistirane reprodukcije |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7846957B2 (sh) |
| EP (1) | EP1381431B1 (sh) |
| JP (1) | JP2004526764A (sh) |
| KR (1) | KR20040012751A (sh) |
| CN (1) | CN100377710C (sh) |
| AR (1) | AR034310A1 (sh) |
| AT (1) | ATE363906T1 (sh) |
| AU (1) | AU2002249041B2 (sh) |
| BG (1) | BG108316A (sh) |
| BR (1) | BR0208968A (sh) |
| CA (1) | CA2444932A1 (sh) |
| CY (1) | CY1108021T1 (sh) |
| CZ (1) | CZ299735B6 (sh) |
| DE (1) | DE60220516T2 (sh) |
| DK (1) | DK1381431T3 (sh) |
| EA (1) | EA010354B1 (sh) |
| EE (1) | EE200300512A (sh) |
| ES (1) | ES2283541T3 (sh) |
| HK (1) | HK1067987A1 (sh) |
| HR (1) | HRP20030838A2 (sh) |
| HU (1) | HUP0303795A2 (sh) |
| IL (2) | IL158395A0 (sh) |
| MX (1) | MXPA03009446A (sh) |
| NO (1) | NO20034245L (sh) |
| NZ (1) | NZ528501A (sh) |
| PL (1) | PL366554A1 (sh) |
| PT (1) | PT1381431E (sh) |
| SI (1) | SI1381431T1 (sh) |
| SK (1) | SK14252003A3 (sh) |
| UA (1) | UA79591C2 (sh) |
| WO (1) | WO2002083240A1 (sh) |
| YU (1) | YU81303A (sh) |
| ZA (1) | ZA200307514B (sh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2491372A1 (en) * | 2002-07-02 | 2004-01-15 | Pharmacia & Upjohn Company Llc | Infertility treatment with exemestane |
| AU2011256088B2 (en) | 2010-05-20 | 2015-03-26 | University Of Saskatchewan | Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal |
| WO2012127501A2 (en) * | 2011-03-11 | 2012-09-27 | Sanzyme Limited | Composition for improving endometrial thickness during ovarian stimulation |
| JP6280501B2 (ja) | 2011-09-08 | 2018-02-14 | メレオ バイオファーマ ２ リミテッド | 性腺機能低下症および関連疾患の処置ためのアロマターゼ阻害剤の使用 |
| US10004723B2 (en) | 2013-04-19 | 2018-06-26 | University Of Saskatchewan | Aromatase inhibitor-releasing intravaginal device |
| CN107648594A (zh) * | 2017-11-08 | 2018-02-02 | 广州市桐晖药业有限公司 | 枸橼酸氯米芬胶囊及其制备方法 |
| CN118286143A (zh) * | 2024-03-20 | 2024-07-05 | 郑州大学第三附属医院(河南省妇幼保健院) | 注射用尿促卵泡素联合来曲唑在制备不孕症的试剂盒中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4289762A (en) * | 1980-06-27 | 1981-09-15 | Merrell Dow Pharmaceuticals Inc. | 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors |
| US4728645A (en) * | 1982-12-21 | 1988-03-01 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors |
| US4845227A (en) * | 1984-06-18 | 1989-07-04 | Eli Lilly And Company | Aromatase inhibitors from azoles |
| US4978672A (en) * | 1986-03-07 | 1990-12-18 | Ciba-Geigy Corporation | Alpha-heterocyclc substituted tolunitriles |
| DE4330237C2 (de) * | 1993-09-02 | 1995-11-30 | Schering Ag | 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| DE59703511D1 (de) | 1996-03-29 | 2001-06-13 | S W Patentverwaltungs Ges M B | Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite" |
| WO1997040846A1 (en) | 1996-04-30 | 1997-11-06 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| DE19622457A1 (de) | 1996-05-24 | 1997-11-27 | Schering Ag | 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO1998058657A1 (en) * | 1997-06-20 | 1998-12-30 | Akzo Nobel N.V. | Gonadotropin releasing hormone antagonist |
| US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
-
2002
- 2002-04-17 AR ARP020101398A patent/AR034310A1/es unknown
- 2002-04-17 CA CA002444932A patent/CA2444932A1/en not_active Abandoned
- 2002-04-17 DK DK02717917T patent/DK1381431T3/da active
- 2002-04-17 EE EEP200300512A patent/EE200300512A/xx unknown
- 2002-04-17 PT PT02717917T patent/PT1381431E/pt unknown
- 2002-04-17 NZ NZ528501A patent/NZ528501A/en not_active IP Right Cessation
- 2002-04-17 ES ES02717917T patent/ES2283541T3/es not_active Expired - Lifetime
- 2002-04-17 US US10/475,172 patent/US7846957B2/en not_active Expired - Fee Related
- 2002-04-17 IL IL15839502A patent/IL158395A0/xx unknown
- 2002-04-17 AT AT02717917T patent/ATE363906T1/de active
- 2002-04-17 SI SI200230565T patent/SI1381431T1/sl unknown
- 2002-04-17 KR KR10-2003-7013483A patent/KR20040012751A/ko not_active Application Discontinuation
- 2002-04-17 SK SK1425-2003A patent/SK14252003A3/sk unknown
- 2002-04-17 CN CNB028123190A patent/CN100377710C/zh not_active Expired - Fee Related
- 2002-04-17 PL PL02366554A patent/PL366554A1/xx not_active Application Discontinuation
- 2002-04-17 JP JP2002581040A patent/JP2004526764A/ja active Pending
- 2002-04-17 MX MXPA03009446A patent/MXPA03009446A/es not_active Application Discontinuation
- 2002-04-17 AU AU2002249041A patent/AU2002249041B2/en not_active Ceased
- 2002-04-17 EP EP02717917A patent/EP1381431B1/en not_active Expired - Lifetime
- 2002-04-17 DE DE60220516T patent/DE60220516T2/de not_active Expired - Lifetime
- 2002-04-17 UA UA20031110267A patent/UA79591C2/uk unknown
- 2002-04-17 WO PCT/CA2002/000522 patent/WO2002083240A1/en active IP Right Grant
- 2002-04-17 BR BR0208968-8A patent/BR0208968A/pt not_active IP Right Cessation
- 2002-04-17 HU HU0303795A patent/HUP0303795A2/hu unknown
- 2002-04-17 EA EA200301129A patent/EA010354B1/ru not_active IP Right Cessation
- 2002-04-17 CZ CZ20033108A patent/CZ299735B6/cs not_active IP Right Cessation
- 2002-04-17 YU YU81303A patent/YU81303A/sh unknown
-
2003
- 2003-09-23 NO NO20034245A patent/NO20034245L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307514A patent/ZA200307514B/en unknown
- 2003-10-14 IL IL158395A patent/IL158395A/en not_active IP Right Cessation
- 2003-10-15 HR HR20030838A patent/HRP20030838A2/xx not_active Application Discontinuation
- 2003-11-05 BG BG108316A patent/BG108316A/bg unknown
-
2005
- 2005-02-15 HK HK05101178A patent/HK1067987A1/xx not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100965T patent/CY1108021T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0109146D0 (en) | Treatment of type 2 diabetes | |
| NO20024586D0 (no) | Metode og preparater for å forhindre hormoninduserte bivirkninger | |
| UA32636C2 (uk) | Засіб для зниження вмісту холестерину в сироватці крові людини | |
| MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| CY1108021T1 (el) | Αναστολη αρωματασης για ενισχυση του ρυθμου εμφυτευσης | |
| NO20101070L (no) | Fremgangsmate til dosering av et medikament, samt doseringsform | |
| RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| PL1656131T3 (pl) | Zastosowanie betainy w leczeniu chromania przestankowego | |
| RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| YU56702A (sh) | Korišćenje fsh za lečenje neplodnosti | |
| WO2002074315A8 (de) | Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie | |
| EP1759734A3 (en) | Aromatase inhibition to enhance assisted reproduction | |
| HUP0101005A2 (hu) | Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére | |
| YU81203A (sh) | Pojedinačna doza inhibitora aromataze za lečenje neplodnosti | |
| IL164317A0 (en) | Statin therapy for enhancing cognitive maintenance | |
| MXPA03009448A (es) | Inhibidores de aromatasa para tratamiento de infertilidad. | |
| IL151878A0 (en) | Pharmaceutical compositions containing t3 | |
| AU2001262378A1 (en) | Method for treating cryptorchidism | |
| NO20005341D0 (no) | Behandling av depresjon og farmasøytiske sammensetninger til dette | |
| MD1854F1 (en) | Method of treatment in the congestive cardiac insufficiency | |
| RU2004125594A (ru) | Применение тиболона при лечение симптомов, связанных с введением лекарств, препятствующих синтезу эндогенного эстрогена | |
| UA36137A (uk) | Спосіб лікування хворих на хронічне легеневе серце | |
| UA30722A (uk) | Спосіб профілактики гнійно-септичних ускладнень у породіль |